# SEYSARA
> **NDA209521** · New Drug Application · Sponsor: ALMIRALL · Approved 2018-10-01
## Drug
- **FDA Application Number:** NDA209521
- **Application type:** New Drug Application
- **Brand name:** SEYSARA
- **Generic name:** SARECYCLINE HYDROCHLORIDE
- **Active ingredients:** SARECYCLINE HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ALMIRALL
- **Manufacturer:** Almirall, LLC
- **First approval:** 2018-10-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209521)
---
*MORVS · CC0 1.0*